Americans are spending billions on drugs that don’t work. The FDA has sped up approvals for some drugs under pressure from patient groups, but that’s allowed some to be sold even before testing was finished.
Since 2014, drug companies made at least $3.6 billion in global sales of medications that have either later been deemed ineffective or had most or all of their uses withdrawn.
